Xavier Compta-Gonzalez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

High Response Rates and Predictors in Patients with CRSwNP Treated With Mepolizumab and Dupilumab: Results From a Prospective, Multicenter Cohort Study.

High Response Rates and Predictors in Patients with CRSwNP Treated With Mepolizumab and Dupilumab: Results From a Prospective, Multicenter Cohort Study.

Journal: American journal of rhinology & allergy

Published: April 06, 2026

Real-world effectiveness of omalizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): findings from CHRINOSOR.

Real-world effectiveness of omalizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): findings from CHRINOSOR.

Journal: Rhinology

Published: February 17, 2026

Real-world effectiveness of omalizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): findings from CHRINOSOR.

Real-world effectiveness of omalizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): findings from CHRINOSOR.

Journal: Rhinology

Published: February 17, 2026

Dupilumab-induced eosinophilia in severe asthma: 2-year follow-up real-life evidence from biologic-naïve and previously treated patients.

Dupilumab-induced eosinophilia in severe asthma: 2-year follow-up real-life evidence from biologic-naïve and previously treated patients.

Journal: Respiratory medicine

Published: January 07, 2026

Nasal Sublesional Bevacizumab Injections as Adjuvant Treatment for Diffuse Sinonasal Exophytic Papillomas.

Nasal Sublesional Bevacizumab Injections as Adjuvant Treatment for Diffuse Sinonasal Exophytic Papillomas.

Journal: Journal of clinical medicine

Published: December 04, 2025

Mepolizumab in Chronic Rhinosinusitis with Severe Nasal Polyposis: Real-Life Spanish Cohort Study.

Mepolizumab in Chronic Rhinosinusitis with Severe Nasal Polyposis: Real-Life Spanish Cohort Study.

Journal: Acta otorrinolaringologica espanola

Published: September 26, 2025

Mepolizumab in chronic rhinosinusitis with severe nasal polyposis: Real-life Spanish cohort study.

Mepolizumab in chronic rhinosinusitis with severe nasal polyposis: Real-life Spanish cohort study.

Journal: Acta otorrinolaringologica espanola

Published: September 26, 2025

Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR).

Real-World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR).

Journal: Clinical and translational allergy

Published: September 09, 2025

Standardisation of sinonasal anatomical terminology in Spanish: An expert consensus.

Standardisation of sinonasal anatomical terminology in Spanish: An expert consensus.

Journal: Acta otorrinolaringologica espanola

Published: August 07, 2025

Comparison of COVID-19 and Non-COVID-19 Tracheostomised Patients: Complications, Survival, and Mortality Risk Factors.

Comparison of COVID-19 and Non-COVID-19 Tracheostomised Patients: Complications, Survival, and Mortality Risk Factors.

Journal: Journal of clinical medicine

Published: December 19, 2024

Skull base surgery via extended endoscopic endonasal approach: Predictors of ear-nose-throat complications.

Skull base surgery via extended endoscopic endonasal approach: Predictors of ear-nose-throat complications.

Journal: Acta otorrinolaringologica espanola

Published: October 30, 2024

Comparison of the EPOS 2020 and POLINA 2.0 guidelines for indicating biologic treatment in adults with chronic rhinosinusitis and nasal polyps.

Comparison of the EPOS 2020 and POLINA 2.0 guidelines for indicating biologic treatment in adults with chronic rhinosinusitis and nasal polyps.

Journal: Acta otorrinolaringologica espanola

Published: October 19, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026